Nordea Investment Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.7M | Buy |
655,995
+562,799
| +604% | +$20.3M | 0.02% | 317 |
|
|
2025
Q1 | $2.88M | Buy |
93,196
+65,403
| +235% | +$2.02M | ﹤0.01% | 635 |
|
|
2024
Q4 | $708K | Sell |
27,793
-551,229
| -95% | -$14M | ﹤0.01% | 849 |
|
|
2024
Q3 | $16.3M | Buy |
579,022
+554,381
| +2,250% | +$15.7M | 0.02% | 340 |
|
|
2024
Q2 | $657K | Hold |
24,641
| – | – | ﹤0.01% | 857 |
|
|
2024
Q1 | $755K | Buy |
24,641
+1,970
| +9% | +$60.3K | ﹤0.01% | 860 |
|
|
2023
Q4 | $634K | Hold |
22,671
| – | – | ﹤0.01% | 887 |
|
|
2023
Q3 | $607K | Hold |
22,671
| – | – | ﹤0.01% | 892 |
|
|
2023
Q2 | $689K | Buy |
22,671
+669
| +3% | +$20.3K | ﹤0.01% | 869 |
|
|
2023
Q1 | $797K | Buy |
22,002
+912
| +4% | +$33K | ﹤0.01% | 835 |
|
|
2022
Q4 | $832K | Sell |
21,090
-860
| -4% | -$33.9K | ﹤0.01% | 806 |
|
|
2022
Q3 | $889K | Buy |
21,950
+1,141
| +5% | +$46.2K | ﹤0.01% | 796 |
|
|
2022
Q2 | $865K | Sell |
20,809
-305,945
| -94% | -$12.7M | ﹤0.01% | 817 |
|
|
2022
Q1 | $12.7M | Buy |
326,754
+9,211
| +3% | +$359K | 0.02% | 361 |
|
|
2021
Q4 | $12.8M | Buy |
317,543
+175,648
| +124% | +$7.08M | 0.02% | 368 |
|
|
2021
Q3 | $5.25M | Buy |
141,895
+135,897
| +2,266% | +$5.02M | 0.01% | 596 |
|
|
2021
Q2 | $246K | Hold |
5,998
| – | – | ﹤0.01% | 976 |
|
|
2021
Q1 | $266K | Hold |
5,998
| – | – | ﹤0.01% | 957 |
|
|
2020
Q4 | $300K | Buy |
+5,998
| New | +$300K | ﹤0.01% | 908 |
|